Leadership Overview
Genomma Lab has 4 executives leading key functions including strategy, finance, operations, and governance.
Driven by a commitment to enhancing health and well-being, Genomma Lab offers a wide range of innovative health and personal care solutions, positively impacting communities and ensuring shareholder satisfaction.
Driven by a commitment to enhancing health and well-being, Genomma Lab offers a wide range of innovative health and personal care solutions, positively impacting communities and ensuring shareholder satisfaction.
Leadership Roles at Genomma Lab
Marco Sparvieri - Chief Executive Officer
Marco Sparvieri, the Chief Executive Officer at Genomma Lab, directs the company's overall strategy and operational execution. Sparvieri guides the organization in delivering innovative health and personal care products designed to enhance well-being across diverse consumer segments. Overseeing global initiatives, the Chief Executive Officer ensures alignment with Genomma Lab's mission to improve quality of life through effective and safe solutions. This leadership position involves fostering a culture of continuous improvement and driving sustainable growth. By championing new product development and market expansion, Marco Sparvieri directly impacts the company's competitive positioning and financial performance. Ultimately, Sparvieri secures long-term value creation for shareholders and stakeholders.
Antonio Galland - Chief Financial Officer
Antonio Galland, the Chief Financial Officer at Genomma Lab, manages all financial operations and strategic fiscal planning. Galland oversees budgeting, forecasting, and capital allocation to support the company's expansion in health and personal care markets. Directing treasury functions, the Chief Financial Officer ensures robust financial health and compliance with regulatory standards across all operational geographies. This critical role involves optimizing financial performance and mitigating risk to safeguard company assets. By analyzing market trends and investment opportunities, Antonio Galland provides essential financial insights that inform executive decision-making. Ultimately, Galland drives financial stability and profitability, reinforcing Genomma Lab's commitment to shareholder satisfaction and sustainable business practices.
Rodrigo Aspra - Founder & President
Rodrigo Aspra, the Founder & President at Genomma Lab, established the company's vision for innovative health and personal care products. Aspra provides foundational leadership and strategic direction, guiding the organization's commitment to enhancing consumer well-being. Overseeing the company's long-term trajectory, the Founder & President ensures adherence to core values and market leadership principles. This enduring role involves shaping the corporate culture and fostering sustainable growth from the company's inception. By leveraging deep industry knowledge and entrepreneurial spirit, Rodrigo Aspra continues to influence Genomma Lab's impact on communities and its dedication to shareholder value. Ultimately, Aspra's legacy drives the company's ongoing pursuit of excellence in health solutions.
Mayda Gonzalez - Chief of Staff
Mayda Gonzalez, the Chief of Staff at Genomma Lab, facilitates strategic initiatives and operational efficiency across the executive team. Gonzalez coordinates cross-functional projects and ensures seamless communication between departments, supporting the delivery of health and personal care solutions. Managing key organizational processes, the Chief of Staff drives the execution of strategic priorities and enhances overall business performance. This role involves streamlining operations and fostering collaboration to achieve Genomma Lab's mission of improving well-being. By optimizing resource allocation and project timelines, Mayda Gonzalez directly contributes to the company's agile response to market demands. Ultimately, Gonzalez strengthens the leadership's capacity to innovate and expand market reach.
Explore Leadership Teams in Manufacturing
Founded in 1781, Takeda Pharmaceutical Company engages in the research, development, manufacturing, and marketing of pharmaceutical products, over-the-counter medicines and quasi-drug consumer products, and other healthcare products. It offers pharmaceutical products in the areas of gastroenterology; oncology; neuroscience; and rare diseases, such as rare metabolic and hematology, and heredity angioedema, as well as plasma-derived therapies and vaccines. The company is headquartered in Tokyo, Japan
Company Leadership RR
DB
WH
FD
Tilray was established in 2018 in British Columbia, Canada. They specialize in the research, cultivation, production and distribution of medical cannabis and cannabinoids.
Company Leadership AF

SS
BM
Since 2006, Pharos Indonesia has been the fastest growing pharmaceutical company in Indonesia, achieving 40% annual growth. In 2009, based on IMS* reports, Pharos became the 4th largest Indonesian pharmaceutical company; jumping from position 12 in just 4 years. Pharos marketing teams have forged strong relationships with major hospital groups as well as individual doctors, including specialists and this ensures strong distribution of our products. No other pharmaceutical manufacturer, nor retail pharmacy group, can compete with the strength of the Pharos-controlled network of almost 2,000 pharmacies spread across Indonesia. Pharos is uniquely positioned to take advantage of the large and fast-growing ASEAN region.
Company Leadership VP
AW
HD
RR
Vanda Pharmaceuticals, founded in 2003, is a biopharmaceutical research and development company focused on creating innovative medicines to improve patient lives. The company leverages advanced technologies including genetics and genomics to guide drug discovery, clinical trials, and commercial strategies. Vanda Pharmaceuticals specializes in developing novel therapeutic approaches and delivery methods for their pharmaceutical products. With operations across North America, Europe, and Asia, the company maintains a global presence in the pharmaceutical industry while continuing to advance medical research and drug development for various health conditions.
Company Leadership BA

PJ
JW